• News
  • SAN DIEGO
  • BioTech

Zogenix pain drug may be abused at higher rate, FDA staff says

Zogenix Inc.'s pure hydrocodone painkiller Zohydro may be abused at a greater rate than combination products on the market, U.S. regulators said.

To continue reading, subscribe now
or
log in to your account
View all comments
User Response
1 UserComments
Fat Chance 7:30pm December 5, 2012

Good point, 4x the abuse rate without tylenol. Sounds like nothing will happen. happy times selling SDP. Company is going to sink without zohydro.

Zogenix Inc.

Company Website

12400 High Bluff Dr. Ste., 650
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ZGNX
1.27
  0.01  
+ 0.79%
617,109,000
5.19
1.07

Zogenix Inc. Executive(s):

Roger Hawley

  • Chief Executive Officer

Stephen Farr

  • President

Ann Rhoads

  • Chief Financial Officer
Subscribe Today!